Healthcare -
Biotechnology - NASDAQ - US
$ 12.29
-8.31 %
$ 1 B
Market Cap
-3.92
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Viridian Therapeutics, Inc.
| Net Income | -270 M |
| Depreciation & Amortization | 1.24 M |
| Capital Expenditures | -511 K |
| Stock-Based Compensation | 42.2 M |
| Change in Working Capital | 0 |
| Others | 5.05 M |
| Free Cash Flow | -233 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (269.9) | (237.7) | (129.9) | (79.4) | (110.7) | (41.9) | (32.7) | (26.5) | (12.7) | (11.3) | (7.9) | (2.2) | (5.6) |
| Depreciation & Amortization | 0 | 0.5 | 0.3 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
| Deferred Income Tax | 0 | 0 | 0 | 1.0 | 56 K | (0.4) | (0.4) | 0 | 0.9 | 0 | 0.2 | 0 | (1.6) |
| Stock Based Compensation | 42.1 | 67.2 | 19.8 | 14.5 | 3.6 | 4.0 | 3.7 | 2.4 | 2.1 | 3.0 | 4.3 | 0 | 7.96 K |
| Other Operating Activities | (4.5) | (4.7) | 54 K | 7.5 | 72.6 | 0.3 | 0.4 | 94 K | 93 K | 0.1 | 1.0 | 1.5 | 2.5 |
| Change in Working Capital | 0 | (9.4) | 16.0 | 1.7 | 4.4 | 1.7 | 1.9 | (4.5) | 2.2 | 1.1 | 0.1 | (0.6) | (1.6) |
| Cash From Operations | (232.3) | (184.2) | (93.8) | (54.6) | (29.8) | (36.1) | (26.8) | (28.2) | (7.2) | (6.9) | (2.2) | (1.2) | (6.2) |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (0.5) | (0.9) | (0.8) | (0.3) | 42 K | 84 K | (0.4) | (0.2) | 3 K | (0.1) | (0.3) | 4.77 K | (0.1) |
| Other Items | (228.1) | (93.4) | (114.3) | (74.0) | (50.4) | 28.3 | (29.5) | 1.3 | 0 | 28 K | 8 K | 10.5 K | 12.5 K |
| Cash From Investing Activities | (228.7) | (94.3) | (115.1) | (74.3) | (50.5) | 28.2 | (29.9) | 1.0 | 3 K | 95 K | (0.3) | 5.68 K | (0.1) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) | (0.4) | 0 | (0.5) | 0 |
| Total Debt Repaid | 0 | 15.0 | 5.0 | 0 | (8.6) | (2.3) | 0 | 5.3 | (0.3) | 76 K | 0.8 | 2.0 | 6.6 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.3) | (0.7) |
| Other Financing Activities | 4.1 | 85.6 | 43.6 | 17.0 | 84.8 | 77 K | (2.6) | (1.4) | 76 K | 50 K | 0 | 78 | 50 K |
| Cash From Financing Activities | 457.7 | 225.7 | 322.2 | 125.3 | 101.3 | 70 K | 41.9 | 52.5 | (0.3) | 12.7 | 7.4 | 1.3 | 5.8 |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | (3.2) | (52.8) | 113.3 | (3.6) | 21.1 | (7.8) | (14.8) | 25.3 | (7.5) | 5.7 | 4.9 | 96.8 K | (0.5) |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (232.8) | (185.1) | (94.6) | (54.9) | (29.8) | (36.1) | (27.3) | (28.4) | (7.2) | (7.0) | (2.5) | (1.2) | (6.3) |